Good morning, ladies and gentlemen and welcome to the Ingredion Third Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions] I would now like to turn the conference over to your speaker host today, Mr. Jason Payant, Vice President of Corporate Finance and Interim Vice President of Investor Relations.

Thank you. Good morning and welcome to Ingredion’s third quarter 2021 earnings call. I'm Jason Payant, Vice President of Corporate Finance and Interim Vice President of Investor Relations. On today's call are Jim Zallie, our President and CEO; and Jim Gray, our Executive Vice President and Chief Financial Officer. We issued our results today in a press release that can be found on our website, ingredion.com, in the Investors section. The slides accompanying this presentation can also be found on the website and were posted today for your convenience. As a reminder, our comments within this presentation may contain forward-looking statements. These statements are subject to various risks and uncertainties and include expectations and assumptions regarding the Company's future operations and financial performance, including the impact of the COVID-19 pandemic. Actual results could differ materially from those predicted in the forward-looking statements and Ingredion assumes no obligation to update them in the future as or if circumstances change. Additional information concerning factors that could cause actual results to differ materially from those discussed during today's conference call or in this morning's press release can be found in the Company's most recently filed annual report on Form 10-K and subsequent reports on Forms 10-Q and 8-K. During this call, we also refer to certain non-GAAP financial measures, including adjusted earnings per share, adjusted operating income and adjusted effective tax rate, which are reconciled to U.S. GAAP measures in Note 2, non-GAAP information, included in our press release and in today's presentation appendix. Now, I'm pleased to turn the call over to Jim Zallie.

Thank you, Jason, and good morning, everyone. We delivered outstanding third quarter top line performance of 17% net sales growth. This reflected well-managed sales execution to meet strong customer demand. In every region, we achieved double-digit sales growth by managing price/mix and partnering with customers to meet changing demand requirements as a result of global supply chain constraints. In a challenging environment and against previously anticipated high, double-digit corn cost inflation, we kept pace with higher input costs to deliver adjusted operating income down 9%. As you recall, in the first half of this year, we delivered significant year-over-year EPS growth, absorbing higher gross corn costs while benefiting from higher co-product values. Taken together, as we balance first half favorability with higher net corn costs in the second half, we are still on track to deliver significant operating income growth for the full year. Now Id like to highlight a few of our sales achievements. As mentioned, we grew net sales by double digits across all regions driven by strong specialty demand and actively managing the terms of our customer contracts, including the pass-through of higher-margin corn and freight costs. EMEA led our growth this quarter with strong specialty demand in Europe and the positive impact of the KaTech acquisition. Asia Pacific also performed exceptionally well driven by contributions from PureCircle and strong overall specialty demand. South America and North America benefited from strong customer demand and the pass-through of higher corn and freight costs. Now Id like to comment on the current supply chain environment that were all reading about. As everyone knows, supply chains globally are currently constrained by ocean container availability, rail congestion, labor shortages and continuing impacts of the pandemic. In addition, as economies continue to open, strong international consumer demand has made the current supply…

Thank you, Jim. And good morning to everyone starting first with our Q3 regional performance north American net sales were up significantly when compared to the prior year north America operating income was $120 million down 9% versus the prior year, the decrease was driven by higher corn and input costs as well as cost absorption related to the ramp up of operations in our plant-based protein facilities. South American net sales were up 16% versus prior year. The increase was driven by favorable price mix, including active contract management to reflect higher corn costs partially offset by a volume decline due to the contribution of our Argentina operations to the, our core joint venture in August south America operating income was $35 million up 21% versus prior year as favorable price mix, more than offset higher corn costs. Excluding foreign exchange impacts adjusted operating income was up 20% in the quarter. Moving to Asia Pacific net sales were up 18% in the quarter. The increase was driven by favorable price mix and higher volumes, primarily from PureCircle. Asia Pacific operating income was $21 million up 17% versus prior year as higher volumes from PureCircle and better price mix were partially offset by higher corn freight and input costs in the region in EMIA net sales increased 22% for the quarter. The increase was due to higher volumes, including our KaTech acquisition, as well as favorable price mix absent foreign exchange sales were up 20% EMEA operating income was $23 million down 8% for the quarter. The decrease was driven by higher corn and energy costs and Pakistan that more than offset higher volumes moving to our income statement, net sales of $1,763 million. We're up 17% for the quarter versus prior year. Gross profit dollars were relatively flat year…

Thanks Jim. Overall, we are very pleased with both the financial performance in the quarter, as well as the strategic progress we continue to make to strengthen our portfolio. Right now, we are focused on supporting our customers as we manage through complex supply chain bottlenecks, which are impacting the entire food supply chain and just as importantly, we are leveraging the expertise developed in our pricing centers of excellence that were built up over the last two years. As we work to offset input cost inflation for the remainder of this year. And next year, we will continue to shape our portfolio towards specialties and look for opportunities to invest in new capabilities and businesses that will strengthen the value propositions inherent in each of our on-trend consumer focused growth. Lastly, we will continue to bring the potential of people, nature and technology together to make life better for all stakeholders. Now let's open the call for questions.

[Operator instructions] Now, first question coming from the line of Ben Bienvenu with Stephens Inc. Your line is open.

So want to ask and focus on the specialty business. You noted the global specialties contributed high-teen sales growth, continuing to drive strong growth across a lot of your products within that segment of your business. You also talked about improvement in the integration of PureCircle. Could you provide some color on what sort of EBIT contribution were seeing from specialties relative to that sales growth that were seeing and what you think the maturation of that contribution will look like over the next year or so as that portfolio continues to mature?

Sure. Jim, do you want to take that?

Hey, Ben, maybe I’ll lead on that. Wave characterized our specialty ingredients portfolio both from a gross margin and from an operating income margin perspective as being greater than the remainder of our portfolio. Traditionally, we see specialty margins in our products in the 30%-plus range, and it can be -- for some niche products, it can be significantly more than that on a gross margin basis. And generally, what we’re seeing is that as we have moved through this year in terms of various input costs, they generally have less of an impact on our specialties because the raw material is a lower portion of our cost of sales. And so as specialty continues to grow both on a volume basis, on a market share gain basis and, therefore, on a revenue basis, were seeing that EBIT growth is somewhat in line with how we talk to the top line growth.

Yeah, I think in our strategic plan, for example, the majority of our gross profit increase over that planned period is coming from specialties. And I think when you saw the most recent four year outlook that we had provided that the percentage of operating income coming from specialties is projected to increase about four percentage points I think over that period, from a standpoint of the weight of the overall portfolio. The other thing that I would add is part of our strategy is to continue to invest in one of our five growth platforms, which is called food systems, which is leveraging the ingredients that are in those other four platforms. Starch-based texturizers, the clean and simple ingredients, sugar reduction and plant-based proteins from a formulation capability standpoint to develop more complete systems for our customers, which typically are higher gross margin and those we have projected that those will grow at a higher rate as well.

Okay. I see. That's great. Thank you. Secondly, I'd like to ask about just capital allocation. You look like, based on the way things are going, you'll probably continue to build cash on the balance sheet, even as you've accelerated, to some extent your buyback activity, you've got a steady, steady dividend at a nice yield you're farther along in integrating peer circle. You noted that the pipeline is interesting and attractive. Could you talk about, when we think about rank ordering your use of cash over the next year or so or the most versus least likely outlets deploy that cash into?

Sure. Yes, Ben, Ill tie your first question to your second question, right, which is that as we grow the specialty portfolio, were really looking for that contribution in terms of operating income growth. So how can we get operating income growth mid-single digits to high single digits? We do that by looking around the globe at where we have capital investments, organic capital investments that our team identifies. And that's really one of our first priorities in terms of capital investment after what I would call our stay-in-business capital. And the reason why is that those opportunities are – they're near and they're adjacent, they're strategic. And our whole team can really operate on our value chain and on the go-to-market opportunity. So for example, were investing in a modified food starch expansion in China. And China is a tremendously underserved market for modified starches, and we can bring great, differentiated product that's sourced locally and made locally and sold into a massive market. So that's the type of opportunities where we first prioritize. I think secondarily then, were really looking at -- were very conscious about the dividend and dividend growth. We've raised the dividend seven years in a row. And then third, we still have excess cash to deploy strategically. And really, it’s a choice between what M&A is there available to us that we think we can prudently go after and do so with a disciplined approach toward ROIC. I think we've proven that we can get synergies out of the acquisitions that we've executed in the past. Still some of that evidence is for us to show. I mean we highlighted here on the call PureCircle and the progress were making on PureCircle going into next year. So M&A, tuck-in M&A, M&A in general is very much a focus for us. And if not, then well go after some share repurchase and be very disciplined about total shareholder return.

That's great. Thanks, Jim. Jim, good luck with the rest of the year.

Now next question coming from the line of Robert Moskow with Credit Suisse. Your line is open.

Hi. A couple of questions. One is on -- in Asia Pac, it looks like you lowered your sales guidance for the year. Is that related to PureCircle? Or is that related to just the challenge of global trade in a tight supply chain environment? And then also, can you elaborate a little more on the yellow pea crop and what that means for your operations? What was your -- what’s your going-in assumption for profitability of that new pea protein business for 2022? And what do you think the potential outcomes are if the crop turns out to be much more expensive?

Yes. Hey Rob, on -- with regard to Asia Pac, really as we looked at what we thought the recovery was in -- from last year in terms of volume, really if you look at Q3 South -- Southern Asia, right, whether its Thailand and Asiani type of regions or even China with its kind of intermittent lockdowns, there’s just been kind of some ups and downs in terms of the volume growth as wave had just starts and stops in various food supply chains as well as kind of ins and outs on foodservice. So I think that, that’s now -- were see that -- we see COVID rates coming down. We see consumer mobility up, thinking a bit more positively on Asia Pac for Q4. So really, when we just take kind of Q3 and what maybe that slight pause had into effect, I think that’s impacting our full year outlook. And it’s -- it really has nothing to do with PureCircle. PureCircle growth is still strong double digits.

And as far as the plant-based protein investment in yellow pea, we continue to remain very bullish on the growth prospects from both South Sioux City and the Vanscoy investments. We absolutely believe that plant-based proteins are going to represent a sizable portion of our specialty portfolio over the next three, four, five years. Were very encouraged by the progress our manufacturing and engineering teams have made to commission two entirely new production facilities in a completely new ingredient category to Ingredion. And the Vanscoy facility, as we indicated, continues to produce at record rates in comparison to previous months. Right now, the focus is on South Sioux City, completing that process stabilization and ramping up that supply to meet customer demand. Our plant-based protein sales in 2021 will be two to three times what they were last year. That said, they will be behind our first year forecast. And that’s why were laser focused on loading the facility and absorbing the costs associated with the new plant start-up. So while this will result in a larger operating loss than we had projected this particular year, were confident in the long-term prospects for the category and for the return on those investments.

Yes. And generally, Rob, I mean, to add, as we see yellow pea cost or the cost of the raw material going up, the first indications are -- is that it’s such a value-added product that raw material pricing can be put through on the higher-end protein isolates in the marketplace.

Okay. So when you say that the loss is larger than expected, is that because the crop is weak? Or is it because of other types of delays.

No, no. So again, we are just commissioning these facilities this calendar year, so the yellow pea cost is not related to that at all. So it’s just related to the merging of the commercial ramp-up of the facilities tied to sales in the first year literally of commissioning both facilities.

Okay. Is it easy to catch up in year two then Jim, like…

We've got a very strong customer pipeline. We’re having very strategic discussions with some of the largest users and projected users of, for example, pea protein isolate and pulse-based concentrates across food and other applications. And so were feeling very good about the prospect going into 2022.

Yeah. Rob, maybe just to help, on South Sioux City, there’s just more fixed costs with that facility just given the complexity of the process. And so the more volume you get through, you absorb the fixed costs and then you get right back on plan.

Okay. Last question in the quarter gross profit margin was below consensus. It, was it in line with what you thought or was a little light?

No, I think it was in line with what we were expecting, recognizing look, in our business, quite a bit of it is in terms of -- as we mentioned, in North America, a portion is variable price, so it’s a fee-type contract. Revenue is going to go up as the course -- the cost of corn goes up, and were really securing kind of our dollar profit per ton for the value-add service that we provide. So I think in terms of gross profit dollars, looking at the various corn cost inflation, which was probably 3/4 of our change in our cost of sales for the quarter, that was very in line with expectations.

Our next question coming from line of Adam Samuelson with Goldman Sachs Group.

Hi. So first question, maybe just to clarify, just as we think about the layout for the fourth quarter, I think the full year guidance implies that adjusted operating profit in 4Q is down 20%-plus year-over-year. And then maybe just help us with where the incremental year-on-year pressures are coming through in 4Q relative to where you were in the third quarter. And I know corn costs are more burdensome in the second half of the year broadly, but it does seem to imply a bigger step-down sequentially, and I’m just trying to make sure were clear on the drivers.

Sure. Thanks, Adam. So in the first -- first, I just want to bring us back to the first nine months of the year. Gross corn costs were in line with our business plan, and we benefited from higher co-product values. In addition, volumes, particularly specialties, were stronger than anticipated due to the snapback of the global economies opening up, inclusive of really very strong foodservice sales. And in the third quarter, we kept pace with higher input costs to deliver operating income in line with our expectations against, again, previously anticipated high double-digit corn cost inflation, and we also delivered very strong price/mix. In quarter four, were anticipating further inflationary cost increases and some supply chain constraints, limiting volume upside. And were obviously imposing price surcharges in-year, which is what wave been doing, and they will just lag some of the increase in input costs. But were taking all that into account as we go into our contracting and pricing for next year with momentum on the pricing side.

Yeah. And Adam, just to remind, right, Q3 is usually a bigger quarter than Q4. And that, as we had previously discussed and as Jim just mentioned, just still managing through, higher corn costs year over year. I mean, that's, that's the primary impact that we're seeing in terms of Q4.

Okay. All right. That’s -- yes, that’s helpful. And then follow-up question, and you kind of alluded to it a little bit in that answer just now, Jim. But also, throughout the call today, you made several allusions to actively managing customer contracts and pricing and being considerably more proactive on that than maybe Ingredion had been historically. I'd love to hear you reflect a little bit about what you're actually doing with the -- on the pricing side to really make sure you're getting that inflation recovery. And is that both in the -- more in the base commodity business than specialty? Is it both -- if its commodity, is that a better supply environment with volumes improving? Or just help me think about how maybe Ingredions kind of pricing discipline is maybe different today than it might have been a couple of years ago?

Yes. We've been emphasizing our -- what we call pricing centers of excellence for the last year-plus. And the best evidence of that is in South America. So South America has developed very strong pricing muscles that have been demonstrated in relationship to the magnitude of price/mix vis-a-vis ForEx devaluation over each successive quarter over the last two years, so much so that I think it was last quarter and this quarter it’s almost a complete neutralization without even the lag. That's one example. So we've shared best practices across the globe and staffed. And were fortunate we did so prior to inflation rearing its head. That's why we're feeling very good. And this particular year, as it relates to extraordinary times call for extraordinary measures, when you're living through inflation in-year, even though were contracted, were looking at each and every contract, where possible, where we can in-year exercise the terms that are in those contracts to put through freight increases of an order of magnitude that offsets those cost increases, surcharges where necessary and any other inflationary increases. So were doing that in each region based on those pricing centers of excellence. And just if I could comment a little bit just on pricing as it relates to the go forward. The increased economic activity and increased industry capacity utilization, we believe, will be favorable to pricing next year. Corn prices are, as we all know, trending in the mid-$5 range for next year, which would imply substantial increases in corn costs. And the industry is contending with the increases in chemicals, packaging, fuel, freight. And all of that's going to need to be offset by pricing. And consistent with our operating model, we expect to pass through higher corn freight input cost to our customers, and that's really been the primary focus to our customers since early summer. And equally, the pace of contracting is likely to be impacted by customers concern for supply as well as the uncertainty around continued inflationary pressures. And I can say for those customers who we have agreed to 2022 commitments at this time, were seeing substantial price increases year-over-year. And well provide a readout on 2022 contracting during our year-end earnings call in February.

Our next question coming from the line of Ken Zaslow with BMO Capital Markets.

Hey, good morning, everyone. Just one bigger picture question. Your cash flow from your cash flow guidance came down a little bit but you're obviously taking up expectations and your cap ex is going down. What is that in reference to just kind of giving that a little color? That'd be helpful.

Sure. Hey, Ken, just as you have higher corn and raw materials, just working from the raw material to the WIP to the finished goods, and then were selling those to customers, so your volume may be up low single, mid-single digits. The price on that ton is benefiting from the pass-through of that higher corn cost. And so, therefore, the invoice that goes to the customer is more. And then, as you just work through the various terms with the customers in terms of their payables as sales grow, we have to put a little bit more money into accounts receivable. And then as that higher raw material cost is passing through our inventory, be it WIP or finished goods, and were holding it, while the number of units may be similar or even slightly more constrained or down year-over-year due to demand, the value per unit, the value per ton is up. And so that's just reflecting in our balance sheet. I really think this is -- as this globally higher corn cost has moved through the balance sheet in 2021, we’ll be back to kind of a more normalized investment in working capital in 2022 and beyond.

Okay. And then in terms of Europe and the energy costs, how transient is that? And do you expect to be able to start passing it through that we would start to see a different trajectory in 2022.

Yeah. I mean, a one significant item as it relates to input costs that we are putting through, as far as price increases, go in your, Europe accounts for 55 Europe accounts for 55% of our sales in EMIA and in accordance with our risk management strategy, we hedge for your, if our natural gas needs and we're covered well into next year. So we're, monitoring the situation and we are, intending, to put through increases, to offset the inflationary increases with energy, as well as other raw materials and other input costs for contracting for next year in Europe.

Okay. And my final question, and we've all kind of beat around the Bush on this. I'm just going to go right after it. How do you finish contracting in the US and do you expect your prices to offset the corn prices going forward and I'll leave it there. And

It's just too early. We're in the midst of contracting as we always are at this point in time. But what I would repeat is that would repeat is that the market given how tight supply demand is related to very strong demand. So that's what we're seeing very strong demand. And we could sell everything that we make and our plants are up or running very hard. And there's acknowledgement if not acceptance in relationship to the need for price increases to offset inflationary increases. And we're seeing that receptivity and it's just too early to say how it's all going to net out, but right now where we sit we're feeling good about the market's understanding and the receptivity for their price increases to offset inflationary increases. Yeah. I think, to add, it's November, we're about a third of the way through, I think our kind of flat contracting and on that, we have seen substantial price increases year over year.

So as the Jim's comment, right, there's still two thirds of our customers out there who are looking at their contracts. And I think, honestly, I think customers are working through budgeting for next year, and they're working through a H how does that fit into, what their overall price increases needed to be on their goods? So we expect it to pick up this should be the time of the year when it should be really, kind of closing out prior to Thanksgiving and the holidays. And that percentage that Jim's cited is totally in line with historical. So it's not anything that's unusual. Great. I really appreciate it, guys.

[Operator instructions] I'm showing no further questions at this time. I will not like to attend the conference call back over to Mr. Jim Zallie for any closing remarks.

Thank you for joining us this morning, everyone. We look forward to a time when we can see each of you again in person. Please note that we are targeting our Investor Day for the first half of 2022, when we expect to be able to accommodate in-person gatherings. And until then, we want to thank you for your continued interest in Ingredion.

Ladies and gentlemen, that does conclude our conference for today. Thank you for your participation. You may now disconnect.